SkinHealth Systems (SKIN) Non Operating Interest Expenses (2022 - 2026)

SkinHealth Systems (SKIN) has reported Non Operating Interest Expenses for 5 consecutive years, with $6.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 51.91% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was $25.3 million, a 118.83% increase from a year earlier, with the FY2025 full-year figure at $19.3 million, up 85.61% from the prior year.
• Non Operating Interest Expenses was $6.3 million for Q2 2026 at SkinHealth Systems, down from $6.3 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $6.4 million in Q4 2025 and troughed at $2.5 million in Q2 2024.
• A 5-year average of $3.9 million and a median of $3.4 million in 2022 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses dropped 28.49% in 2024 and jumped 158.75% in 2025, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $3.4 million in 2022, then dropped by 1.09% to $3.4 million in 2023, then dropped by 26.65% to $2.5 million in 2024, then jumped by 158.75% to $6.4 million in 2025, then dropped by 1.22% to $6.3 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $6.3 million (Q2 2026), $6.3 million (Q1 2026), and $6.4 million (Q4 2025), per Business Quant data.